Shigeki Nanjo, Wei Wu, Niki Karachaliou, Collin M Blakely, Junji Suzuki, Yu-Ting Chou, Siraj M Ali, D Lucas Kerr, Victor R Olivas, Jonathan Shue, et al. Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer. The Journal of clinical investigation. 2022. 132. 13
Koushiro Ohtsubo, Kunio Miyake, Sachiko Arai, Koji Fukuda, Chiaki Suzuki, Hiroshi Kotani, Azusa Tanimoto, Akihiro Nishiyama, Shigeki Nanjo, Kaname Yamashita, et al. Methylation of Tumor Suppressive miRNAs in Plasma from Patients With Pancreaticobiliary Diseases. Cancer diagnosis & prognosis. 2022. 2. 3. 378-383
Kouji Izumi, Hiroaki Iwamoto, Hiroshi Yaegashi, Takahiro Nohara, Kazuyoshi Shigehara, Yoshifumi Kadono, Shigeki Nanjo, Tadaaki Yamada, Koshiro Ohtsubo, Seiji Yano, et al. Androgen replacement therapy for cancer-related symptoms in male: result of prospective randomized trial (ARTFORM study). Journal of cachexia, sarcopenia and muscle. 2021. 12. 4. 831-842
Koji Fukuda, Sakiko Otani, Shinji Takeuchi, Sachiko Arai, Shigeki Nanjo, Azusa Tanimoto, Akihiro Nishiyama, Katsuhiko Naoki, Seiji Yano. Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancer. Cancer science. 2021. 112. 9. 3784-3795
Jeffrey J Quinn, Matthew G Jones, Ross A Okimoto, Shigeki Nanjo, Michelle M Chan, Nir Yosef, Trever G Bivona, Jonathan S Weissman. Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts. Science (New York, N.Y.). 2021. 371. 6532